Assessment of Level of Adherence to Anti Retroviral Therapy among Adult HIV Infected Patients in Mekelle Hospital, Northern Ethiopia
Clinical Medicine Research
Volume 4, Issue 2, March 2015, Pages: 50-57
Received: Oct. 4, 2014;
Accepted: Oct. 18, 2014;
Published: Mar. 6, 2015
Views 2940 Downloads 156
Afewerki Kahsay Kidanemariam, Tigray Regional Health Beareau, HIV prevention and control case team, Mekelle, Ethiopia
Gebremedhin Gebreegziabiher Gebrehiwot, Adigrat Univerity, College of Medicine and Health Sceinces, department of Public Health, Adigrat, Ethiopia
Introduction: HIV/AIDS is one of the most destructive epidemics the world has ever witnessed. Non-adherence to the proposed antiretroviral regimen is considered to be one of the greatest dangers to the response to treatment on an individual level and the dissemination of resistant viruses on the community level. An adherent patient is defined as one who takes > 95% of the prescribed doses. Objective: To assess the level of adherence and associated factors among adult HIV/AIDS patients receiving Highly Active Antiretroviral Therapy in Mekelle Hospital, Northern Ethiopia. Methods: A cross sectional study was carried out from January 1, 2013 to July 30, 2013 among 382 adult PLWHA (>=18 years) attending HAART clinic at Mekelle Hospital. Data was collected by a combination of structured questionnaire and document review. The data was entered and cleaned using Epi-Info; transported to SPSS 16.0 version for final analysis. Bivariate and multivariate analyses were performed to identify factors associated with adherence. Results: The rate of self reported adherence in the study based on the Schedule and indicator of the dose, time measurement in the last 7 days was (78.3%). Females were more adhered than males (185(87.7%)). Alcohol users have poor adherence than non alcohol users with 70.5% and 82.2% level of adherence respectively. Sex and educational status of the study participants were significantly associated with level of adherence with AOR (95% CI) of 3.81(2.18, 6.69) and 2.60(1.43, 4.71) respectively. Conclusion: The level adherence we found, 78.2%, is still very low considering the WHO recommendation of 95%. Sex and educational status of the study participants were significantly associated with level of adherence with AOR (95% CI) of 3.81(2.18,6.69) and 2.60(1.43,4.71) respectively. More focus should be given to males and individuals with low educational status to improve level of adherence and to assure the efficacy of HAART in prolonging the life of PLWHA. Adherence is a process, not a single event, and adherence support must, therefore, be integrated into regular clinical follow up. Investigation of factors related with long-term adherence would require longer follow-up than the present study.
Afewerki Kahsay Kidanemariam,
Gebremedhin Gebreegziabiher Gebrehiwot,
Assessment of Level of Adherence to Anti Retroviral Therapy among Adult HIV Infected Patients in Mekelle Hospital, Northern Ethiopia, Clinical Medicine Research.
Vol. 4, No. 2,
2015, pp. 50-57.
Unaids/who: aids epidemic update 2007. geneva, switzerland.
Unaids/who: aids epidemic update. 2009, unaids/09.36e/jc1700e
Ethiopian Federal Ministry of Health HIV/AIDS Prevention and Control Office. Country progress report in HIV/AIDS response. Addis Ababa: Ethiopian Federal Ministry of Health HIV/AIDS Prevention and Control Office, 2012.
Ministry of Health of Ethiopia: Guideline for Implementation of Antiretroviral Therapy in Ethiopia, Addis Ababa Ethiopia. 2005.
Spire B, Duran S, Souville M, et al. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002;54:1481–96.
Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, Hellmann NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO: Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med 1998, 339(5):307-11.
Harrigan PR, Hogg RS, Dong WW, et al: Predictors of HIV drug resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis 2005, 191:339-47.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis E, Squire C, et al: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000, 133:21-30.
Singh N, Berman S, Swindells S. Justis JC, Mohr JA, Squier C and Wegener MM. Adherence of human immunodeficiency virus– infected patient to antiretroviral therapy. Clinical Infectious Diseases. 1999; 29:824-830.
Tiyou et al. Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource limited setting of southwest Ethiopia, AIDS Research and Therapy 2010, 7:39
Alemayehu A, Kifle W, Sofonias G, Belaineh G, Kebede D. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia, BMC Public Health. 2008; 8:265.
Tadios Y, Davey G: Antiretroviral treatment adherence and its correlates among people living with HIV/AIDS on highly active antiretroviral therapy in Addis Ababa, Ethiopia. EMJ 2006, 44(2):237-244.
Mengesha A, Worku A: Assessment of antiretroviral treatment among HIV infected persons in the Ministry of Defense Hospitals. AAU; MPH Thesis 2005
Carrieri P, Cailleton V, Le Moing V, Spire B, Delllanonica P, Bouvet E, Raffi F, Journot V, Moatti JP, APROCO study group The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort. J Acquir Immune Defiic Syndr. 2001;28:232–39.
Schonnesson LN, Diamond WPM, Michael Ross, Williams M, Bratt G. Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. AIDS Care. 2006;18:246–253.
Bonolo PF, César CC, Acurcio FA, et al: Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil. AIDS 2005, 19(suppl 4):s5-s13.
Ejigu et al. Anti-retroviral therapy adherence and its determinants among adult patients living with HIV/AIDS in South West Ethiopia: a facility-based cross sectional study, Gaziantep Med J 2014;20(1):52-58.
Beyene KA, Gedif T, Gebre-Mariam T, Engidawork E. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia. Pharmacoepidemiol Drug Saf 2009;18(11):1007-15.
Potchoo Y, Tchamdja K, Balogou A, Pitche VP, Guissou IP, Kassang EK. Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa. BMC Clin Pharmacol 2010;10:11.
Nyambura A. Factors that influence non–adherence to antiretroviral therapy (ART) among human immunodeficiency virus and acquired immune deficiency syndrome (HIV/ AIDS) patients in Kenya, Kenyatta University, Kenya. Department Of Public Health, 2009;68-71.
Orrell C, Bangsberg DR, Badri M, Wood R (2003) Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 17: 1369-1375.
Endrias Markos, Alemayehu Werku, Gail davey. adherence to ART in PLWHA at Yirgalem Hospital, South Ethiopia, Ethio.J.health Dev2008;22(2).
Alagaw A, Godana W, Taha M,Dejene T (2013) Factors Associated with Antiretroviral Treatment Adherence among Adult Patients in Wolaita Soddo Hospital. J Trop Dis 1: 125. doi: 10.4172/2329-891X.1000125.